The invention relates to methods for treating autoimmune inner ear disease (AIED). In particular, the invention relates to treating AIED with humanized anti-IL-1β antibodies or fragments thereof, especially monovalent, highly potent anti-IL-1β antibody fragments. The invention further relates to antibodies, compositions and kits for use in the methods of the invention.